Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
HRTX on Nasdaq
Adam Morgan - trading volume in the past year for HERON THERAPEUTICS, INC. /DE/
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
8,753,290 |
$11,379,277 |
$1.30 |
30 Jan 2026 |
By Velan Capital Master Fund LP |
|
|
| Common Stock |
123,737 |
$160,858 |
$1.30 |
30 Jan 2026 |
Direct |
|
|
| Stock Option (Right to Buy) |
35,900 |
$62,107 |
$1.73 |
31 Jan 2025 |
Direct |
Common Stock |
|
| Series A Convertible Preferred Stock |
70,012 |
|
|
08 Aug 2025 |
By Velan Capital Master Fund LP |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.